Pregled bibliografske jedinice broj: 388124
Continuous glucose monitoring system based on microdialysis in assessment of glycaemia in type 2 diabetic microalbuminuric patients – a pilot study
Continuous glucose monitoring system based on microdialysis in assessment of glycaemia in type 2 diabetic microalbuminuric patients – a pilot study // Book of Abstracts WCN 2007
Rio de Janeiro, Brazil, 2007. (poster, međunarodna recenzija, sažetak, stručni)
CROSBI ID: 388124 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Continuous glucose monitoring system based on microdialysis in assessment of glycaemia in type 2 diabetic microalbuminuric patients – a pilot study
Autori
Eržen Jurišić, Dubravka ; Radman, Maja ; Ljutić, Dragan ; Glavaš, Duška ; Kovačić, Nataša
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni
Izvornik
Book of Abstracts WCN 2007
/ - , 2007
Skup
World congress of nephrology 2007
Mjesto i datum
Rio de Janeiro, Brazil, 21.04.2007. - 25.04.2007
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
continuous glucose monitoring; diabetic nephropathy
Sažetak
Background and Aims:The progression of diabetic nephropathy is related to the degree of glycemic control. We used the continuous glucose monitoring system based on microdialysis (GlucoDay, A.Menarini) to evaluate blood glucose excursions in microalbuminuric type 2 diabetic patients. Patients and methods: Fifty type 2 diabetic and microalbuminuric ( rate of albumin excretion 20-199 ug/min) patients on two times/day NPH insulin and before meals three times/day lispro insulin were enrolled in our pilot study. Their characteristics were as follows: 24 male, 26 female, mean age 65 years, diabetes duration 9, 8 +3, 2 years, mean HbA1c was 8, 33 % + 1, 08 %. A 48 hours monitoring was obtained to all patients on the beginning and after 3 months observation period. The information was downloaded and analysed retrospectively by a diabetologist. Results: At baseline, time spent in the euglycemic range (glucose between 3.9 and 8.0 mmol/l) was 46, 87 ± ; 10, 22 %. At end point, time in the euglycemic range increased on 62, 37 ± ; 12, 20 %. Time spent in the hypoglycemic range (glucose below 3.9 mmol/l) was 9.23 ± ; 2.83 % at baseline. At end point, time in the hypoglycemic range decreased 6.6 ± ; 1.68 %. HbA1c was significantly improved from the value 8.33 ± ; 1.08 % observed at the beginning to 7.64 ± ; 0, 92 % after 3 months. Conclusions: This pilot study suggested that continuous glucose monitoring offers to diabetics and diabetologists more informations about glucose excursions and influences on achieving better metabolic control.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
062-0620529-0517 - Regeneracija mozga, perifernog živca i skeletnog mišića u šećernoj bolesti (Jerković, Romana, MZOS ) ( CroRIS)
Ustanove:
Klinički bolnički centar Rijeka
Profili:
Dragan Ljutić
(autor)
Nataša Kovačić
(autor)
Dubravka Jurišić-Eržen
(autor)
Maja Radman
(autor)